Navigation Links
Scientists in hot pursuit of first new drug for global killer in 50 years
Date:3/24/2010

This World TB Day (March 24), researchers at Sydney's Centenary Institute announce they have made an exciting discovery that could lead to the first new drug for Tuberculosis (TB) in almost fifty years.

Dr Nick West, Associate Faculty of the Mycobacterial group at Centenary, is looking at the genetics of TB in the hope they will reveal a way to reduce the impact of one of the deadliest diseases in the world.

Dr West, explains, "When someone is infected with TB they either become sick immediately or the disease stays inactive, latent."

"Unfortunately, the antibiotics we use to fight TB aren't effective against latent TB and can only be used when the disease becomes active. This is a major problem as 1 out of 10 people who have latent TB will develop the active disease, becoming sick and contagious."

Dr West and his team have made a vital discovery in the development of a new drug that could cure TB in the latent stage. If the project succeeds, it will be the first new treatment for TB since 1962.

This is exciting news given that TB kills almost 2 million people each year. One third of the world's population, or two billion people, are infected with TB. Every second of every day another person is infected.

And worse, TB is at Australia's doorstep with the fastest growing incidence of the disease occurring in South East Asia. Luckily, the Centenary Institute, Australasia's largest TB research facility, is mounting a winning fight against this global killer.

Dr West explains, "We have investigated a protein that is essential for TB to survive and we have had some success in developing a drug that will inhibit this protein. Our goal over the coming months is to find out the full extent of this drug's potential."

"If we can figure out a way to treat TB when it's in a latent stage, then we could save millions of lives throughout the world."


'/>"/>

Contact: LauraBeth Albanese
l.albanese@centenary.org.au
61-295-656-118
Research Australia
Source:Eurekalert

Page: 1

Related medicine news :

1. Top Scientists Explore the Origin of Life in Annual Lasker Lecture at Scripps Research Institute Florida Campus
2. Anti-obesity drugs unlikely to provide lasting benefit according to scientists
3. University of Michigan scientists identify chemical in bananas as potent inhibitor of HIV infection
4. Scientists Find Stem Cells in Hair That Can Become Skin
5. MRC scientists announce advance in understanding bodys natural defenses
6. Scientists identify microRNA as possible cause of chemotherapy resistance
7. Scientists Find Key to Hormone-Resistant Prostate Tumors
8. University of Michigan scientists discover bone marrow can harbor HIV-infected cells
9. MSU scientists develop more effective method of predicting lead-poisoning risk
10. Scientists Unravel Mysteries of Intelligence
11. Scientists Spot Genetic Fingerprints of Individual Cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... Kathleen Doheny HealthDay ... Chronic sleep loss is rampant in America, and work commitment ... is the No. 1 sleep killer," said Dr. Mathias Basner, ... the University of Pennsylvania Perelman School of Medicine. A ... older, found that work is the main activity exchanged for ...
(Date:12/15/2014)... Cancer researchers have just published an important new report ... pleural mesothelioma. Surviving Mesothelioma has just posted an article ... to read it now. , Doctors at Harvard, ... York’s Langone Medical Center performed complete genetic analyses on ... effort to pinpoint the genes that are most likely ...
(Date:12/15/2014)... Main Street Dental Team ( http://www.MainStreetDentalTeam.com ), ... a new study providing evidence on the impact of ... children. , Sufficient enough evidence already exists showing a ... juice drinks, with the onset of tooth decay. One ... listed as 100% fruit juice, meaning it is completely ...
(Date:12/15/2014)... a leading mobile app development company , custom ... which allows users to keep track of wines they ... right wine. At the center of WineMatch is ... wine information. All this information is assembled to help ... are close counterparts to one another are called Matches. ...
(Date:12/15/2014)... 15, 2014 Health Dialog, a ... today that it has received Patient Oriented Accreditation ... for its Disease Management (DM) Programs for asthma, ... coronary heart disease and diabetes. This marks the ... Health Dialog’s Disease Management (DM) Programs, reaffirming Health ...
Breaking Medicine News(10 mins):Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:New Study Reveals Genetic Mutations That May Trigger Mesothelioma, According to Surviving Mesothelioma 2Health News:Main Street Dental Team, Unionville’s Most Innovative Dental Clinic, Comments on New Study Relating Pure Fruit Juice to Poor Oral Hygiene 2Health News:Use WinMatch Connect App to Keep Track of Wines You Like 2Health News:Health Dialog Receives NCQA Accreditation for Disease Management Programs 2
... traditional Indian medicine, a four-year degree course in Ayurveda ... for the first time in eastern India//. ... its kind in the country after Gujarat, would be ... in joint venture with West Bengal Health Department under ...
... postmenopausal women has shown that those who indulged in six ... a 3 percent reduction in risk of type 2 diabetes, ... the scientists were not able to place their finger on ... yet they strongly feel that the presence of antioxidants and ...
... Now, Britain's reputed pediatricians, nearly 30 of them have called ... ,Infact they have issued a letter to the public ,that ... triple shots of MMR. ,They have appealed to the ... furore over the supposed link between MMR and autism, especially ...
... a University of Alabama biostatistician has compiled a report on ... assisted in this venture by 19 other scientists in the ... at more than 100 studies on the reasons for obesity ... could be an answer ,* Inadequate sleep: Sleep ...
... in New Zealand. Hence Pharmac decided to fund for the new ... level. // ,It has decided to give Insulin Glargine ... , Murray Dear who is the president for the Diabetes New ... the incidence of diabetes. ,He also said that the ...
... could increase their chances of breast cancer, a study says. ... Agency for Research on Cancer in France analysed 1,600 women. ... susceptibility genes) mutations who had undergone a chest X-ray were ... who had never undergone the procedure. ,Women who ...
Cached Medicine News:
(Date:12/15/2014)... N.Y. , Dec. 15, 2014 As ... SPL (Structured Product Labeling) markup language standard, content teams ... understanding and skills to work with the standard. Starting ... series of three webinars on the benefits and the ... one-hour webinars will be facilitated by Howard Shatz ...
(Date:12/14/2014)... GREENVILLE, S.C. , Dec. 14, 2014  ChartSpan, ... become the most downloaded iPhone and iPad medical app ... Photo - http://photos.prnewswire.com/prnh/20141214/164317 ... with the ability to request, manage and send electronic ... of innovative entrepreneurs who grew tired of waiting for ...
(Date:12/13/2014)... 12, 2014 Mindray Medical International Limited ("Mindray", ... and marketer of medical devices worldwide, today announced shareholder ... held in Hong Kong on ... shareholders voted to re-elect incumbent directors Li Xiting and ... shareholders did not re-elect Peter Wan as ...
Breaking Medicine Technology:Data Conversion Laboratory Helping Life Sciences Content Producers Understand the Impact and Benefits of Structured Product Labeling 2Data Conversion Laboratory Helping Life Sciences Content Producers Understand the Impact and Benefits of Structured Product Labeling 3ChartSpan Becomes The Most Downloaded Medical App in America 2ChartSpan Becomes The Most Downloaded Medical App in America 3Mindray Announced Shareholder Resolutions Post 2014 Annual General Meeting 2
... Sept. 22 AstraZeneca today,announced that the United ... additional six-month period of exclusivity to market CASODEX(R),(bicalutamide) ... 1, 2009. AstraZeneca has been working with the ... of CASODEX in a pediatric,setting but will not ...
... a biotech company,focused on developing novel therapeutics for ... commercial and manufacturing expertise to,the Company,s senior management ... clinical trials of ENB-0040 for the treatment of,hypophosphatasia., ... Enobia,s Vice President, Chief,Commercial Officer, and Jayant Aphale, ...
Cached Medicine Technology:AstraZeneca Receives Six Months Pediatric Exclusivity for CASODEX(R) (bicalutamide) from the FDA 2AstraZeneca Receives Six Months Pediatric Exclusivity for CASODEX(R) (bicalutamide) from the FDA 3AstraZeneca Receives Six Months Pediatric Exclusivity for CASODEX(R) (bicalutamide) from the FDA 4Enobia Pharma Appoints Industry Veterans with Commercial and Manufacturing Expertise to Expand Senior Management Team 2Enobia Pharma Appoints Industry Veterans with Commercial and Manufacturing Expertise to Expand Senior Management Team 3
Compression Bra...
Post-Surgical compression garments...
... The Albumin Cobalt Binding (ACB®) Test is ... Modified Albumin (IMA®) by measuring the cobalt ... serum sample. First identified in the early ... comes in contact with ischemic tissue in ...
... Test is a clinical chemistry assay that ... the cobalt binding capacity of albumin in ... the early 1990s, IMA is produced when ... tissue in the heart. During ischemia, the ...
Medicine Products: